銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

Balaxi Pharmaceuticals
BALAXI ?NSE

Balaxi Pharmaceuticals

?23.690.02 (0.08%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
22.50
Today’s high
23.90
52 week low
15.20
52 week high
54.70
Open price
23.85
Previous close
23.67
Live volume
21,643
Lower circuit
22.49
Upper circuit
24.85

Fundamentals

Market Cap
?131Cr
ROE
0.57%
P/E Ratio(TTM)
91.04
EPS(TTM)
0.26
P/B Ratio
0.52
Dividend Yield
0.00%
Industry P/E
33.86
Book Value
45.12
Debt to Equity
0.23
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
?73.63
+1.36%
Profit (Cr)
?0.61
+96.77%
020406080
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-1%
3Y CAGR+1%
Profit growthValue
1Y (TTM)-93%
3Y CAGR-19%

About

Balaxi Pharmaceuticals is a globally recognized company enhancing healthcare by providing a wide range of pharmaceuticals in the frontier markets of Latin America and Africa. Its vision is to establish strong product portfolios and channel networks, aiming to expand into 20 frontier markets over the next 5 years. The company's mission is to become a top pharmaceutical player in these markets, focusing on scale, healthy margins, and quality growth in a balanced way. Its diverse portfolio includes a well-balanced mix of generics and branded generics, with products like antibiotics, analgesics, and anti-malaria drugs. As part of its backward integration strategies, it is establishing a pharmaceutical formulation facility in Hyderabad, India to ensure quality and reduce dependency. The company has an impressive track record of 960 product registrations in multiple countries, with another 700 underway to expand its presence.;
CEO/MD
Mr. Ashish Maheshwari
Founded in
1942
NSE symbol
BALAXI

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
65.99%
Retail And Others
31.45%
Other Domestic Institutions
2.56%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
?8,429.50
-99.50 (1.17%)
L
    H
    21,286.25113.5124.39
    PfizerPFIZER
    ?4,538.70
    -0.60 (0.01%)
    L
      H
      20,766.7328.744.94
      ?1,454.00
      +23.40 (1.64%)
      L
        H
        19,822.7430.615.08
        ?788.10
        +6.00 (0.77%)
        L
          H
          19,386.3932.583.81
          2026
          28
          May
          Quarterly & Annual Result
          Release date
          28
          Jan
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          5
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks

          銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

          xxfseo.com